Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LCN8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CEBPA-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
EGLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GABRB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C18orf8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDH15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGIR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CADPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM122A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRP12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BSND - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H3E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBFADN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on